Constipation and botanical medicines: An overview

Phytotherapy Research

Volumn 29, Issue 10, 2015, Pages 1488-1493

  Cirillo, Carla ^a   Capasso, Raffaele ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

anthraquinone; botanical medicine; constipation; nutraceutical

Indexed keywords

AGAR; ALOIN; ANTHRAQUINONE; ANTHRONE; CASANTHRANOL; CASCARA; CASCAROSIDE A; CASCAROSIDE B; CASCAROSIDE C; CASCAROSIDE D; DRUG METABOLITE; FRANGULA BARK; GLYCOSIDE; GUM TRAGACANTH; HYDROXYANTHRACENE; NUTRACEUTICAL; RHEIN; SENNA EXTRACT; SENNOSIDE; SENNOSIDE A; SENNOSIDE B; SENNOSIDE C; SENNOSIDE D; SENNOSIDE E; SENNOSIDE F; UNCLASSIFIED DRUG; ANTHRAQUINONE DERIVATIVE; LAXATIVE; SENNOSIDE A&B;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ALOE; ANOREXIA; CONSTIPATION; DIET SUPPLEMENTATION; DIETARY FIBER; DISCOLORATION OF THE URINE; DRUG INDUCED DISEASE; FLUID INTAKE; FRANGULA; HEMORRHOID; HEMORRHOID CONGESTION; HERBAL MEDICINE; HUMAN; KELP; LIFESTYLE; MELANOSIS OF THE COLON; NAUSEA; PHYSICAL ACTIVITY; QUALITY OF LIFE; REVIEW; RHUBARB; SENNA; URINARY TRACT DISEASE; ADULT; FEMALE; MEDICINAL PLANT; PHYTOTHERAPY; RHEUM; THERAPEUTIC USE; TRADITIONAL MEDICINE;

ABDOMINAL PAIN; ADULT; ALOE; ANTHRAQUINONES; CONSTIPATION; DIETARY FIBER; FEMALE; HUMANS; LAXATIVES; MEDICINE, TRADITIONAL; NAUSEA; PHYTOTHERAPY; PLANTS, MEDICINAL; QUALITY OF LIFE; RHEUM; SENNA EXTRACT;

EID: 84943555101     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5410     Document Type: Review

References (43)

1. Bae SH,. 2014. Diets for constipation. Pediatr Gastroenterol Hepatol Nutr 17: 203-208.
2. Benyamin R, Trescot AM, Datta S, et al., 2008. Opioid complications and side effects. Pain Physician 11: S105-120.
3. van den Berg AJ, Labadie RP,. 1984. Anthraquinones, anthrones and dianthrones in callus cultures of Rhamnus frangula and Rhamnus purshiana. Planta Med 50: 449-451.
4. Bharucha AE, Pemberton JH, Locke GR 3rd.,. 2013. American Gastroenterological Association technical review on constipation. Gastroenterology 144: 218-238.
5. Bliss DZ, Savik K, Jung HJ, Whitebird R, Lowry A, Sheng X,. 2014. Dietary fiber supplementation for fecal incontinence: a randomized clinical trial. Res Nurs Health 37: 367-378.
6. Booth FW, Roberts CK, Laye MJ,. 2012. Lack of exercise is a major cause of chronic diseases. Compr Physiol 2: 1143-1211.
7. Brunton L, Chabner B, Knollman B,. 2011. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th edn. Hardcover McGraw-Hill Companies, Inc: New York.
8. Capasso F, Gaginella TS,. 1997. Laxative. A Practical Guide. Springer-Verlag: Italia, Milano.
9. Capasso F, Borrelli F, Capasso R, et al.,. 1998. Aloe and its therapeutic use. Phytother Res 12: S124-S127.
10. Capasso F, Gaginella TS, Grandolini G, Izzo AA,. 2003. Phytotherapy: A Quick Reference to Herbal Medicine. Springer-Verlag: Heidelberg, Germany.
11. Capasso R, Laudato M, Borrelli F,. 2013. Meeting report: First National Meeting on Aloe, April 20-21, 2013, Isernia, Italy. New perspectives in aloe research: from basic science to clinical application. Nat Prod Commun 8: 1333-1334.
12. Caraceni A, Hanks G, Kaasa S, et al., 2012. European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13: e58-68.
13. Chang L,. 2004. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 (Suppl 7): 31-39.
14. Chey WD, Kurlander J, Eswaran S,. 2015. Irritable bowel syndrome: a clinical review. JAMA 313: 949-958.
15. Drossman DA,. 2006. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130: 1377-1390.
16. El-Salhy M, Svensen R, Hatlebakk JG, Gilja OH, Hausken T,. 2014. Chronic constipation and treatment options. Mol Med Rep 9: 3-8.
17. Eswaran S, Muir J, Chey WD,. 2013. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 108: 718-727.
18. Ewe K, Ueberschaer B, Press AG,. 1993. Influence of senna, fibre, and fibre-+-senna on colonic transit in loperamide-induced constipation. Pharmacology 47 (Suppl 1): 242-248.
19. Fu J, Wang Z, Huang L, et al.,. 2014. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res 28: 1275-1283.
20. Guilera M, Balboa A, Mearin F,. 2005. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 100: 1174-1184.
21. Kim SK, Bhatnagar I,. 2011. Physical, chemical, and biological properties of wonder kelp-Laminaria. Adv Food Nutr Res 64: 85-96.
22. Longstreth GF, Thompson WG, Chey WD, et al., 2006. Functional bowel disorders. Gastroenterology 130: 1480-1491.
23. Mascolo N, Capasso R, Capasso F,. 1998. Senna: a safe and effective drug. Phytother Res 12: S143-S145.
24. McMillan SC, Williams FA,. 1989. Validity and reliability of the constipation assessment scale. Cancer Nurs 12: 183-188.
25. Menees S, Saad R, Chey WD,. 2012. Agents that act luminally to treat diarrhoea and constipation. Nat Rev Gastroenterol Hepatol 9: 661-674.
26. Mohammadi R, Hosseini-Safa A, Ehsani Ardakani MJ, Rostami-Nejad M,. 2015. The relationship between intestinal parasites and some immune-mediated intestinal conditions. Gastroenterol Hepatol Bed Bench 8: 123-131.
27. NICE. 2012. Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults. Clinical guidelines 140, NICE, London, UK.
28. Norton C,. 1996. The causes and nursing management of constipation. Br J Nurs 5: 1252-1258.
29. Ross H,. 1998. Constipation: cause and control in an acute hospital setting. Br J Nurs 7: 907-913.
30. Sangsawang B,. 2014. Risk factors for the development of stress urinary incontinence during pregnancy in primigravidae: a review of the literature. Eur J Obstet Gynecol Reprod Biol 178: 27-34.
31. Shin GH, Toto EL, Schey R,. 2015. Pregnancy and postpartum bowel changes: constipation and fecal incontinence. Am J Gastroenterol 110: 521-529.
32. Sobczak M, Sałaga M, Storr MA, Fichna J,. 2014. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol 49: 24-45.
33. Suares NC, Ford AC,. 2011. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 33: 895-901.
34. Sykes NP,. 1998. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 12: 375-382.
35. Szigethy E, Schwartz M, Drossman D,. 2014. Narcotic bowel syndrome and opioid-induced constipation. Curr Gastroenterol Rep 16: 410.
36. Tack J, Müller-Lissner S,. 2009. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 7: 502-508.
37. Tack J, Müller-Lissner S, Stanghellini V, et al.,. 2011. Diagnosis and treatment of chronic constipation-a European perspective. Neurogastroenterol Motil 23: 697-710.
38. Thies F, Masson LF, Boffetta P, Kris-Etherton P,. 2014. Oats and bowel disease: a systematic literature review. Br J Nutr 112 (Suppl 2): S31-43.
39. Thomas JR, Cooney GA, Slatkin NE,. 2008. Palliative care and pain: new strategies for managing opioid bowel dysfunction. J Palliat Med 11 (Suppl 1): S1-19-S21-2.
40. Thompson GW,. 1979. The Irritable Gut: Functional Disorders of the Alimentary Canal. University Park Press: Baltimore, USA.
41. Wang X, Yin J,. 2015. Complementary and alternative therapies for chronic constipation. Evid Based Complement Alternat Med 2015: 396396.
42. Winney J,. 1998. Constipation. Nurs Stand 13: 49-53.
43. Yang J, Wang HP, Zhou L, Xu CF,. 2012. Effect of dietary fiber on constipation: a meta analysis. World J Gastroenterol 18: 7378-7383.